Member Info for trader250

And you were spot on too.

Sorry to hear this but I bailed out a while ago. As I warned , servicing the Covid loan was an issue. Got a bit of abuse but hope most folk saw the warnings

As mentioned a while ago, Covid loans an issue to service, high turnover of scientists, orders are from abroad (not uk). ODX may justifiably feel they have been sold down the river by the government but they are still not an approved UK test. Still watching.

Issue is revenues are under strain. Covid loans have to be serviced. Covid LFTs will be here only for short term and there is increasing competition. Not for the faint-hearted.

I see my pur of 88682 shares is showing as a "sell" on LSE. I was originally in at 11 and 15 and have added. Lots more to look forward to. Like the fact that CF has plenty of skin in the game.

The fall will have further to go. The Yellen effect, increased competition among miners and with mining more difficult and less profitable than before compounded with the shortage of ASIC machines will probably lead to further falls.

I agree. I was in Ethereum in late 2017 with HL's ETH ETF but FCA have now pulled the plug on that derivative so only existing holders can trade. Could see 125p today.

All on cue...

ARB is a pure BTC mining play and the consensus is that BTC will head up even further as banks and hedge funds etc now investing in significant quantity. ARGO will go way higher no doubt about it.

Depends on what your overall position is. You should always have a strategy. I have £16k in here and my tgt is 120p in the short-term and will top-slice £6k and let the rest ride. I expect 200p in the near term. Wait an hour after the US opens - should see @90p by close.

Compared to RIOT, ARB is mining more BTC much more efficiently than RIOT and the market cap is @10% of RIOT's. I see a significant upside with 200p in the short term.

my mistake - their forecast is $146,000...

Don't battle with BTC. JPM forecasting BTC price of $126,000...

...and it's been a long time since MHRA application. At this rate, SP will be in 30s before xmas. Sneller and L7G sells a huge red flag.

Yes indeed. I am just back from my dog walk in the park having listen to Imperial College on Radio4 discussing the Human Challenge trial. ORPH is looking very promising.

David Evans is so wealthy and has several (large) positions is several companies. He does not need this cash.

I just bought £25k with HL no problems at all. Is your software up to date on your phone/iPad?

ODX should not have to go begging on VOX et al. I believe most of the orders are for India and the far East. In any event, I am out with my £25k sale this morning. Good Luck with this one. I am intrigued with Novacyt - their CEO always appears to be on national tv which can only be good for them.

The UK Rapid Test Consortium (includes Omega) are compiling the results from the recently completed self-test usability study and are currently liaising with the MHRA regarding gaining home use approval.

Once approval for home-use is granted, Omega would of course issue an RNS.

The UK Rapid Test Consortium (includes Omega) are compiling the results from the analyses performance at Ulster University and Abingdon Health laboratories, as well as the data from the recently completed self-test usability study and are currently liaising with the MHRA on this data and remain in dialogue with them regarding gaining home use approval.
Once approval for home-use is granted Omega would of course issue an RNS.